"Hyperlipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions with excess LIPIDS in the blood.
| Descriptor ID |
D006949
|
| MeSH Number(s) |
C18.452.584.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperlipidemias".
Below are MeSH descriptors whose meaning is more specific than "Hyperlipidemias".
This graph shows the total number of publications written about "Hyperlipidemias" by people in this website by year, and whether "Hyperlipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 2 | 3 | 5 |
| 2002 | 6 | 1 | 7 |
| 2003 | 3 | 2 | 5 |
| 2004 | 6 | 3 | 9 |
| 2005 | 7 | 3 | 10 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 3 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 3 | 7 |
| 2014 | 2 | 3 | 5 |
| 2015 | 5 | 3 | 8 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 4 | 1 | 5 |
| 2019 | 4 | 2 | 6 |
| 2020 | 4 | 2 | 6 |
| 2021 | 3 | 1 | 4 |
| 2022 | 10 | 0 | 10 |
| 2023 | 4 | 0 | 4 |
| 2024 | 3 | 0 | 3 |
| 2025 | 2 | 2 | 4 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperlipidemias" by people in Profiles.
-
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. N Engl J Med. 2024 09 12; 391(10):899-912.
-
Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War Veterans. J Am Heart Assoc. 2023 10 03; 12(19):e029575.
-
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open. 2022 02 01; 5(2):e2148172.
-
Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). Am J Cardiol. 2021 08 15; 153:142-144.
-
Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med. 2020 08; 21(8):1016-1021.
-
Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis. Am J Physiol Heart Circ Physiol. 2019 10 01; 317(4):H793-H810.
-
Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort. PLoS One. 2019; 14(4):e0215575.
-
Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access. J Vasc Surg. 2017 Mar; 65(3):775-782.
-
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
-
Postprandial effects on arterial stiffness parameters in healthy young adults. Vasc Med. 2015 Dec; 20(6):501-8.